89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 35 filers reported holding 89BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $324,307 | -79.2% | 40,488 | -69.8% | 0.00% | -80.0% |
| Q1 2024 | $1,560,388 | +79.7% | 134,054 | +72.4% | 0.01% | +66.7% |
| Q4 2023 | $868,556 | -79.7% | 77,758 | -72.0% | 0.01% | -81.8% |
| Q3 2023 | $4,285,556 | -4.0% | 277,562 | +17.8% | 0.03% | -13.2% |
| Q2 2023 | $4,464,695 | -17.3% | 235,604 | -48.0% | 0.04% | -26.9% |
| Q1 2023 | $5,399,935 | -11.6% | 453,246 | -5.6% | 0.05% | +2.0% |
| Q4 2022 | $6,110,947 | +201.8% | 480,043 | +37.2% | 0.05% | +200.0% |
| Q3 2022 | $2,025,000 | +157.3% | 349,860 | +43.4% | 0.02% | +112.5% |
| Q2 2022 | $787,000 | +1610.9% | 243,974 | +1899.8% | 0.01% | – |
| Q1 2022 | $46,000 | -95.8% | 12,200 | -73.2% | 0.00% | -100.0% |
| Q4 2020 | $1,108,000 | -23.6% | 45,500 | -19.5% | 0.02% | -46.4% |
| Q3 2020 | $1,450,000 | +105.7% | 56,500 | +110.5% | 0.03% | +64.7% |
| Q4 2019 | $705,000 | – | 26,840 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
| TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
| DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
| RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
| BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
| Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
| Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
| Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
| Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |